CN103816221A - 一种治疗高血压的药物 - Google Patents

一种治疗高血压的药物 Download PDF

Info

Publication number
CN103816221A
CN103816221A CN201410075172.5A CN201410075172A CN103816221A CN 103816221 A CN103816221 A CN 103816221A CN 201410075172 A CN201410075172 A CN 201410075172A CN 103816221 A CN103816221 A CN 103816221A
Authority
CN
China
Prior art keywords
drug
extract
present
treating hypertension
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410075172.5A
Other languages
English (en)
Inventor
李燕梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410075172.5A priority Critical patent/CN103816221A/zh
Publication of CN103816221A publication Critical patent/CN103816221A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明涉及一种治疗高血压的药物，由以下重量的成分制备而成：罗布麻提取物2g、丹参酮提取物1g、吲达帕胺20mg、缬沙坦6g，本发明对高血压具有显著的疗效。

Description

一种治疗高血压的药物
技术领域
 血压的发病率在我国呈逐年攀升趋势，且向低龄化蔓延，目前治疗药物较多，但治疗效果不甚理想，严重影响到患者的身心健康，目前临床常用的降压药主要有钙离子拮抗剂 、血管紧张素转化酶抑制剂、血管紧张素受体拮抗剂、利尿剂，和受体阻断剂等类，这些药物从不同的作用机制达到了治疗高血压的目的。
背景技术
    本发明涉及一种药物，具体涉及一种治疗高血压的药物。
发明内容
为了解决上述技术问题，本发明提供了一种治疗高血压的药物组合物。
本发明的技术方案如下：一种治疗高血压的药物，由以下重量的成分制备而成：罗布麻提取物2g、丹参酮提取物1g、吲达帕胺20mg、缬沙坦6g。
本发明所述罗布麻提取物的主要有效成分为金丝桃苷，含量不低于1%。
制备方法：取以上各组分，加入辅料，制备成药学上可接受的剂型。
本发明药物对原发性和继发性高血压到具有显著的疗效。
具体的临床资料如下：
资料与方法
研究对象： 选择2009年以来来诊高血压患者100例，纳入标准参照《中国高血压防治指南》。
治疗方法：服用本发明药物，每一一次，一次100mg的原药材量。
诊断标准：
显效：DBP整体下降至正常范围内，降幅大于mmHg，或者DBP未达到正常范围内，降幅小于10mmHg；好转：DBP达到正常范围内，降幅小于10mmHg；
或者DBP未达到正常范围内，但降幅大于10mmHg同时小于20mmHg；无效：DBP降幅小于10mmHg，同时DBP高于正常血压范围。
疗效观察
   服用本发明药物4周后，显效86例，好转14例，有效率100%。
从以上实验可以看出，本发明对高血压具有显著的疗效。
具体实施方式
    下面结合实施例对本发明作进一步的说明。
  实施例1
按以下重量称取：罗布麻提取物20g、丹参酮提取物10g、吲达帕胺2g、缬沙坦60g，混匀后可加入药学上适宜的辅料，如糊精、淀粉等制备成颗粒剂、片剂、胶囊剂等剂型。 

Claims (1)

1.一种治疗高血压的药物，其特征在于，由以下重量的成分制备而成：罗布麻提取物2g、丹参酮提取物1g、吲达帕胺20mg、缬沙坦6g。
CN201410075172.5A 2014-03-04 2014-03-04 一种治疗高血压的药物 Pending CN103816221A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410075172.5A CN103816221A (zh) 2014-03-04 2014-03-04 一种治疗高血压的药物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410075172.5A CN103816221A (zh) 2014-03-04 2014-03-04 一种治疗高血压的药物

Publications (1)

Publication Number Publication Date
CN103816221A true CN103816221A (zh) 2014-05-28

Family

ID=50751702

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410075172.5A Pending CN103816221A (zh) 2014-03-04 2014-03-04 一种治疗高血压的药物

Country Status (1)

Country Link
CN (1) CN103816221A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4295839A1 (en) * 2022-06-20 2023-12-27 KRKA, d.d., Novo mesto Combination of valsartan and indapamide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030152651A1 (en) * 2000-12-21 2003-08-14 Tianjin Tasly Pharmaceutical Co., Ltd., China Herbal composition for angina pectoris, method to prepare same and uses thereof
CN102397363A (zh) * 2010-09-14 2012-04-04 鲍贵震 一种治疗高血压的中药

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030152651A1 (en) * 2000-12-21 2003-08-14 Tianjin Tasly Pharmaceutical Co., Ltd., China Herbal composition for angina pectoris, method to prepare same and uses thereof
CN102397363A (zh) * 2010-09-14 2012-04-04 鲍贵震 一种治疗高血压的中药

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
刘娟: "缬沙坦合并吲达帕胺治疗高血压疗效观察", 《中国医学创新》, vol. 10, no. 23, 15 August 2013 (2013-08-15) *
南京中医药大学: "《中药大辞典》", 31 March 2006, article "丹参 罗布麻" *
武轶群等: "复方抗高血压药物在我国的应用", 《临床合理用药杂志》, vol. 04, no. 32, 30 August 2011 (2011-08-30) *
贺青军等: "复方丹参滴丸联合缬沙坦片治疗原发性高血压的临床观察", 《中医药导报》, vol. 15, no. 04, 28 April 2009 (2009-04-28), pages 15 - 17 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4295839A1 (en) * 2022-06-20 2023-12-27 KRKA, d.d., Novo mesto Combination of valsartan and indapamide
WO2023247435A1 (en) * 2022-06-20 2023-12-28 Krka, D.D., Novo Mesto Bilayer tablets of valsartan and indapamide

Similar Documents

Publication Publication Date Title
TWI757228B (zh) 含有槲皮素配糖體之筋萎縮抑制劑
McQuade et al. Anti-colorectal cancer chemotherapy-induced diarrhoea: current treatments and side-effects
Lee et al. Chaga mushroom extract induces autophagy via the AMPK-mTOR signaling pathway in breast cancer cells
Tomasoni et al. Effects of treatment strategy on endothelial function
RU2015155283A (ru) Фармацевтическая комбинация, содержащая метроформин и дигидрокверценин, и ее применение для лечения рака
RU2007132964A (ru) Дозированные формы активных веществ, содержащих гидроксистильбен, для лечения климактерических затруднений
Chen et al. Modified Sijunzi decoction can alleviate cisplatin-induced toxicity and prolong the survival time of cachectic mice by recovering muscle atrophy
HUE026719T2 (en) Use of extracts from Filipendula to treat and prevent chronic pain conditions
WO2013076487A1 (en) Phytocannabinoids for use in the treatment of intestinal inflammatory diseases
US20180296521A1 (en) Methods and compositions for treating gastrointestinal inflammation
AU2017272098A1 (en) Improved therapeutic index of anti-immune checkpoint inhibitors using combination therapy comprising a PHY906 extract, a Scutellaria baicalensis GeorgI (S) extract or a compound from such extracts
JP2016505050A5 (zh)
JP6121556B2 (ja) ハーブサプリメントおよびその使用の方法
Zhang et al. Efficacy of Gastrosis No. 1 compound on functional dyspepsia of spleen and stomach deficiency-cold syndrome: a multi-center, double-blind, placebo-controlled clinical trial
CN103816221A (zh) 一种治疗高血压的药物
Qu et al. Bidirectional effects of methanol extract of Wei-Chang-An pill on gastrointestinal transit and the spasmolytic activity on isolated rat jejunum
CN104740112A (zh) 番茄红素和葡萄籽组合物在制备治疗关节炎药物中的应用
CN103479970B (zh) 一种治疗风湿性关节痛的外用药物
CN104758451A (zh) 一种治疗痛风的中药组合物
Yarnell Herbal medicine for insomnia
CN101829188B (zh) 一种治疗泌尿系感染和结石病的药物
CN104027411A (zh) 一种用于治疗骨质疏松症的中药
CN102552827B (zh) 一种治疗癫痫的药剂
Xin et al. Zhengzhou University, Zhengzhou, China
Datta-Paulin et al. 40 Supportive Care and Survivorship

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20140528

RJ01 Rejection of invention patent application after publication